Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Iceland Genomics Corporation National Cancer Institute (NCI) |
---|---|
Information provided by: | National Cancer Institute (NCI) |
ClinicalTrials.gov Identifier: | NCT00346008 |
RATIONALE: Studying the genes expressed in samples of blood from patients with cancer and their family members may help doctors identify biomarkers related to cancer.
PURPOSE: This clinical trial is studying genes to identify melanoma in patients in Iceland and their family members.
Condition | Intervention |
---|---|
Melanoma (Skin) |
Procedure: high performance liquid chromatography Procedure: laboratory biomarker analysis Procedure: mutation analysis Procedure: questionnaire administration |
Study Type: | Observational |
Official Title: | Genetic Epidemiologic Studies of Melanoma in Iceland |
Estimated Enrollment: | 2500 |
Study Start Date: | October 2005 |
Estimated Primary Completion Date: | June 2006 (Final data collection date for primary outcome measure) |
OBJECTIVES:
OUTLINE: Participants and patients undergo blood collection and complete lifestyle questionnaires. All patients and population-based controls have DNA samples sequenced for MC1R. Demographic and epidemiologic data on all study participants is collected. Sequencing of the major melanoma susceptibility genes CFDKN2A, CDK4, and MC1R is also performed.
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
DISEASE CHARACTERISTICS:
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
Iceland | |
Iceland Genomics Corporation | Recruiting |
Reykjavik, Iceland, 105 | |
Contact: Contact Person 354-525-3600 |
Study Chair: | Alisa Goldstein, PhD | National Cancer Institute (NCI) |
Study ID Numbers: | CDR0000551606, NCI-06-C-N026, NBCI-03-033-CM, NBCI-01-087-CM, 999906026 |
Study First Received: | June 27, 2006 |
Last Updated: | December 31, 2008 |
ClinicalTrials.gov Identifier: | NCT00346008 |
Health Authority: | Unspecified |
melanoma recurrent melanoma stage I melanoma |
stage II melanoma stage III melanoma stage IV melanoma |
Neuroectodermal Tumors Nevus, Pigmented Neoplasms, Germ Cell and Embryonal Neuroepithelioma |
Nevus Recurrence Neuroendocrine Tumors Melanoma |
Neoplasms Neoplasms by Histologic Type Neoplasms, Nerve Tissue Nevi and Melanomas |